Efficacy and Safety of Baricitinib in Lupus Nephritis

preview_player
Показать описание
Dr. Yuz Yusof discusses abstract OP0053 presented at EULAR 2023 in Milan, Italy.
  1. RheumNow
  2. Rheumatoid
  3. arthritis
  4. Rheumatology
  5. Lupus
  6. Vasculitis
Рекомендации по теме
Efficacy and Safety 0:06:11

Efficacy and Safety of Baricitinib in Lupus Nephritis

Efficacy and Safety 0:06:03

Efficacy and Safety of Phase III Trial of Guselkumab in PsA: Drs. Yusof and Coates

Efficacy and safety 0:04:52

Efficacy and safety of treating alopecia areata with ritlecitinib

Discussing Rheumatology: JAK 0:07:59

Discussing Rheumatology: JAK Inhibitor Monotherapy in RA

Efficacy and safety 0:06:02

Efficacy and safety of tofacitinib following inadequate response to conventional antirheumatic drugs

Baricitinib in patients 0:07:09

Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs

Baricitinib versus placebo 0:05:38

Baricitinib versus placebo or adalimumab on patient-reported outcomes in rheumatoid arthritis

Olumiant (Baricitinib) how 0:03:03

Olumiant (Baricitinib) how to use: Uses, Dosage, Side Effects, Contraindications

JAK Inhibitors Show 0:02:06

JAK Inhibitors Show Promising Efficacy in Rheumatoid Arthritis Treatment

Promising Safety Outlook 0:03:53

Promising Safety Outlook for Rituximab and Baricitinib in Vaccinated Patients

Safety of JAK 0:59:47

Safety of JAK Inhibitors: benefits, risks, problems and solutions

Baricitinib (OLUMIANT®): Evidence-Based 0:38:05

Baricitinib (OLUMIANT®): Evidence-Based Health Information Related to COVID-19

Hair Loss (Alopecia 0:04:01

Hair Loss (Alopecia Areata)Treatment * NEW* FDA Approved New drug - Olumiant (Baricitinib)

Recent Advances in 0:32:16

Recent Advances in the Management of Rheumatoid Arthritis

Janet E. Pope 0:01:42

Janet E. Pope MD, MPH, FRCPC: Baricitinib's Impact on Pain in Patients with RA

JAK-Inhibition in Immune-Mediated 0:43:42

JAK-Inhibition in Immune-Mediated Diseases (IMiDs)

Rheumatology Author Roy 0:21:11

Rheumatology Author Roy Fleischmann: Baricitinib Monotherapy

Discussing Rheumatology: Tofacitinib 0:07:32

Discussing Rheumatology: Tofacitinib safety and dose-switching in RA

The Expanding Role 0:36:51

The Expanding Role of JAK Inhibitors Across IMIDs

Two Phase 3 0:03:01

Two Phase 3 Trials of Baricitinib for Alopecia Areata

My opinion about 0:00:59

My opinion about JAK inhibitor drugs for alopecia.

Baricitinib for Alopecia 0:02:04

Baricitinib for Alopecia | NEJM

A Potential Treatment 0:04:48

A Potential Treatment for Patients With a Combination of Rheumatoid arthritis, Lupus, and Alopecia

Baricitinib for Alopecia 0:05:13

Baricitinib for Alopecia Areata: Updates from the BRAVE trial

visit shbcf.ru